Split, Croatia & NYC, US – September 17, 2024 – Apiotix Technologies, in partnership with NextGen, is excited to announce that Apinol360, a next-generation natural retinol alternative active ingredient, will be available in the North American market in 2025. Demonstrating a remarkable 34% reduction in wrinkles at a 3% concentration over four weeks in clinical trials, Apinol360 effectively combats both aging and inflammaging.
Key Features of Apinol360:
– Clinically Proven Efficacy: Apinol360 provides a robust anti-wrinkle and anti-inflammaging solution, surpassing traditional retinol in performance without its harsh side effects.
– Advanced Natural Formula: Tailored for sensitive skin, it harnesses the soothing powers of phenolic compounds for a gentle yet effective treatment.
– Market Introduction: Apinol360 will soon be incorporated into skincare products across North America, offering a new tool for fighting the signs of aging.
Contact Information:
For more details, about integrating Apinol360 into your products, please contact:
– NextGen Actives
 418 Broadway STE N
 Albany, NY 12207
 +1 917 (456) 5676
 info@nextgenactives.com
 www.nextgenactives.com
– Apiotix Technologies
 21000 Split
 Croatia
 apiotix@apiotix.eu
 www.apiotix.io/apinol360
Bozo Radic, COO of Apiotix Technologies, said, “With Apinol360, we are not just introducing a new product but are paving the way for the future of skincare. We invite skincare professionals and enthusiasts to explore how this innovative active ingredient can transform their product offerings and meet the needs of their clients.”
Media Contact
Company Name: NextGen Actives
Contact Person: Media Relations
Country: United States
Website: www.nextgenactives.com
